AMGN
AMGN
Amgen Inc.
$337.21
+$0.76 (+0.23%)
Mkt Cap: $181.99B
Home / AMGN / Financial Statements

Amgen Inc. (AMGN) Financial Statements

Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.

Metric TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue
$37.24B
$36.74B ↑9.9%
$33.42B ↑18.6%
$28.19B ↑7.1%
$26.32B ↑1.3%
$25.98B
Cost of Revenue
$10.63B
$10.73B ↓16.6%
$12.86B ↑52.8%
$8.41B ↑31.4%
$6.41B ↓0.7%
$6.45B
Gross Profit
$26.61B
$26.01B ↑26.5%
$20.57B ↑4.0%
$19.77B ↓0.7%
$19.92B ↑2.0%
$19.52B
R&D Expenses
$7.51B
$6.97B ↑16.9%
$5.96B ↑24.7%
$4.78B ↑7.9%
$4.43B ↓29.9%
$6.32B
SG&A Expenses
$6.95B
$7.05B ↓0.6%
$7.10B ↑14.8%
$6.18B ↑14.1%
$5.41B ↑0.9%
$5.37B
Operating Income
$11.78B
$10.68B ↑47.1%
$7.26B ↓8.1%
$7.90B ↓17.4%
$9.57B ↑25.2%
$7.64B
Interest Expense
$2.70B
$2.75B ↓12.7%
$3.15B ↑9.7%
$2.88B ↑104.5%
$1.41B ↑17.5%
$1.20B
Income Tax
$1.29B
$1.26B ↑143.7%
$519.00M ↓54.4%
$1.14B ↑43.3%
$794.00M ↓1.7%
$808.00M
Net Income
$7.80B
$7.71B ↑88.5%
$4.09B ↓39.1%
$6.72B ↑2.5%
$6.55B ↑11.2%
$5.89B
EBITDA
$17.34B
$15.84B ↑18.6%
$13.36B ↓9.8%
$14.80B ↑21.6%
$12.17B ↑7.7%
$11.30B
EPS
14.37
14.23 ↑88.2%
7.56 ↓39.5%
12.49 ↑3.1%
12.11 ↑17.8%
10.28
Shares Out (Diluted)
2.17B
542.00M ↑0.2%
541.00M ↑0.6%
538.00M ↓0.6%
541.00M ↓5.6%
573.00M